Head-to-head · Cost-Efficiency Index
Omzo vs FormBlends
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Omzo
Cost-first shoppers who want not clearly assessable without pricing transparency; unsuitable to recommend confidently in a price comparison.
Visit OmzoFormBlends
Cost-first shoppers who want not applicable as a direct provider -- functions as a research/referral hub, not a prescriber.
Visit FormBlendsThe verdict
Omzo takes it, leading the Cost-Efficiency Index 42 to 41. Omzo is a multi-condition telehealth brand offering semaglutide, tirzepatide, and branded Ozempic access alongside women's hormone, sexual health, and skin/hair services. FormBlends still earns a C — Cost-first shoppers who want not applicable as a direct provider -- functions as a research/referral hub, not a prescriber.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Omzo.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Omzo | FormBlends |
|---|---|---|
| Cost-Efficiency Index | 42/100 | 41/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #514 | #519 |
Omzo
42/100Where the value is
- Broad multi-condition offering beyond weight loss (hormones, sexual health, skin, hair)
- States semaglutide and tirzepatide are both available
- Emphasizes licensed clinician review of every plan
The tradeoffs
- No pricing disclosed anywhere without completing a personal-data intake quiz
- No medical director named
FormBlends
41/100Where the value is
- Large self-reported provider directory (7,200+ profiles) and clinical research library
- Transparent about its own limitations, including an explicit pricing-may-be-stale disclaimer
- Claims 47-state coverage via its 503A pharmacy network of partner providers
The tradeoffs
- Not itself a licensed prescriber -- explicitly disclaims being a medical practice
- No verifiable direct pricing; site itself warns its listed provider prices may be outdated
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.